Massively‐parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary-Reference-Cited by-同舟云学术

Massively‐parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary

Published:2013-11-12 Issue:4 Volume:231 Page:413-423
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:The Journal of Pathology

Author:

Tothill Richard W¹²,Li Jason¹,Mileshkin Linda¹³,Doig Ken¹,Siganakis Terence¹,Cowin Prue¹,Fellowes Andrew¹,Semple Timothy¹,Fox Stephen¹,Byron Keith⁴,Kowalczyk Adam⁵,Thomas David¹,Schofield Penelope¹,Bowtell David D¹²³⁶

Affiliation:

1. The Peter MacCallum Cancer Centre East Melbourne VIC Australia

2. The Department of Pathology University of Melbourne Parkville VIC Australia

3. The Sir Peter MacCallum Department of Oncology University of Melbourne Parkville VIC Australia

4. Healthscope Advanced Pathology Clayton VIC Australia

5. National (ICT) Australia The University of Melbourne Parkville VIC Australia

6. The Department of Biochemistry University of Melbourne Parkville VIC Australia

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/path.4251

Reference64 articles.

1. Cancer of unknown primary site

2. Switching benchmarks in cancer of unknown primary: From autopsy to microarray

3. An Expression-Based Site of Origin Diagnostic Method Designed for Clinical Application to Cancer of Unknown Origin

4. Multicenter Validation of a 1,550-Gene Expression Profile for Identification of Tumor Tissue of Origin

5. Molecular Profiling in Unknown Primary Cancer: Accuracy of Tissue of Origin Prediction

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers of systemic inflammation provide additional prognostic stratification in cancers of unknown primary;Cancer Medicine;2024-02

2. The practical utility of AI-assisted molecular profiling in the diagnosis and management of cancer of unknown primary: an updated review;Virchows Archiv;2023-11-24

3. Mutation-Attention (MuAt): deep representation learning of somatic mutations for tumour typing and subtyping;Genome Medicine;2023-07-07

4. Six-year experience of Australia’s first dedicated cancer of unknown primary clinic;British Journal of Cancer;2023-05-24

5. CUP-Syndrom – Diagnostik aus Sicht der Pathologie;Die Radiologie;2023-04-20